We all age. And while humanity’s life expectancy has increased dramatically in the modern era, we still struggle with the inevitable health issues our bodies face as we get up in the years.
Ascendis’ parathyroid hormone replacement therapy wins European approval – Pharmaceutical Technology
Share this article Human parathyroid hormone is found in low levels in patients with hypoparathyroidism. Yorvipath is a prodrug of the hormone. Image credit: Shutterstock/Kateryna